Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples

A Latsuzbaia, J Tapp, T Nguyen, M Fischer… - … and Infectious Disease, 2016 - Elsevier
Analytically accurate human papillomavirus (HPV) genotyping methods are required to
assess the impact of HPV vaccination. The aim of this study was to evaluate the analytical …

Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art

ZQ Toh, PV Licciardi, J Fong, SM Garland, SN Tabrizi… - Vaccine, 2015 - Elsevier
Human papillomavirus (HPV) infection is the primary cause of genital warts, some
oropharyngeal cancers and anogenital cancers, including cervical, vagina, vulvar, anal and …

Genital Warts in Women Vaccinated against HPV in Childhood: A Systematic Review

R Malheiro, C Magalhães, CC Dias, AG Rodrigues… - Vaccines, 2024 - mdpi.com
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection among
young women. Notably, more than ten years after the introduction of HPV vaccination …

Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review

KM Elfström, E Herweijer, K Sundström… - Current opinion in …, 2014 - journals.lww.com
Existing cervical screening techniques are effective; however, programs should consider
implementing HPV DNA testing where applicable and further process developments for …

Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa

N Mugo, NA Ansah, D Marino, A Saah… - Human vaccines & …, 2015 - Taylor & Francis
Due to sporadic and not easily accessible cervical cancer screening, human papillomavirus
(HPV)-related cervical cancer is a leading cause of cancer death in Sub-Saharan African …

Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine—an interrupted time series analysis …

K Thöne, J Horn, R Mikolajczyk - BMC infectious diseases, 2017 - Springer
Background Shortly after the human papillomavirus (HPV) vaccine recommendation and
hence the reimbursement of vaccination costs for the respective age groups in Germany in …

Early evidence of the effectiveness of the human papillomavirus vaccination program against anogenital warts in Manitoba, Canada: a registry cohort study

K Willows, S Bozat-Emre, CH Righolt… - Sexually transmitted …, 2018 - journals.lww.com
Background We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: Population-based cross-sectional survey of Czech women …

M Petráš, V Adámková - Vaccine, 2015 - Elsevier
Background To assess the impact of a quadrivalent human papillomavirus vaccine (4HPV)
in women at increased risk of genital warts (GWs) acquisition. Methods The study was …

Human Papillomavirus (HPV) infection and risk behavior in vaccinated and non-vaccinated paraguayan young women

ML Bobadilla, V Villagra, H Castro, M von Horoch… - Pathogens, 2024 - mdpi.com
Cervical cancer is a global health concern and ranks fourth among the most prevalent
cancers in women worldwide. Human papillomavirus (HPV) infection is a known precursor …

[HTML][HTML] Rates and predictors of genital warts burden in the Czech population

M Petráš, V Adámková - International Journal of Infectious Diseases, 2015 - Elsevier
Objective To describe the burden and the predictors of genital warts (GWs) in Czech men
and women. Methods A population-based cross-sectional study was conducted of 32 974 …